Edwards Lifesciences EW

HealthcareMarket cap $50B2 connections

Edwards Lifesciences makes transcatheter heart valves that replace diseased aortic valves without open-heart surgery. Its TAVR technology has transformed cardiac care - now used in 100,000+ procedures annually. Edwards also makes advanced hemodynamic monitoring systems used in ICUs globally.

Open Edwards Lifesciences's Company Hub Simulate a merger Supply chain See it on the map

Partners 1

Strategic partnerships, joint products and alliances

MedtronicHealthcare · $113BCompeting transcatheter heart valve platforms

Competitors 2

Companies it competes with

MedtronicHealthcare · $113BCardiac valve rivalry
Boston ScientificHealthcare · $64BTranscatheter valve competition

Other Healthcare companies

Eli Lilly Johnson & Johnson AbbVie Novo Nordisk Merck UnitedHealth Thermo Fisher AstraZeneca Amgen Novartis

Embed this on your site

Show Edwards Lifesciences's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=EW" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="Edwards Lifesciences on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.